Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: a True Effect or a Bias? A Systematic Review & Meta-Analysis

被引:24
|
作者
Leshem, Regina [1 ]
Bar-Oz, Benjamin [2 ]
Diav-Citrin, Orna [1 ,3 ]
Gbaly, Siham [1 ]
Soliman, Jessica [1 ]
Renoux, Christel [4 ]
Matok, Ilan [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Ein Kerem Campus, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Minist Hlth, Israeli Teratol Informat Serv, Jerusalem, Israel
[4] McGill Univ, Montreal, PQ, Canada
关键词
SSRI's; SNRI's; antidepressants; ASD; ADHD; prenatal exposure; pregnancy; MATERNAL ANTIDEPRESSANT USE; PLACENTAL-TRANSFER; PRETERM BIRTH; FUNNEL-PLOT; DEPRESSION; EXPOSURE; OUTCOMES;
D O I
10.2174/1570159X19666210303121059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background and objective: An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to study this association and to look for sources of bias by performing a systematic review and meta-analysis. Methods: Medline, Embase, and the Cochrane Library were searched up to June 2019 for studies reporting on ASD and ADHD in the Offspring following exposure during pregnancy. We followed the PRISMA 2009 guidelines for data selection and extraction. Outcomes were pooled using random-effects models and odds ratios (OR), and 95% confidence intervals (CI) were calculated for each outcome using the adjusted point estimate of each study. Results: Eighteen studies were included in the meta-analysis. We found an association between SSRIs/SNRIs prenatal use and the risk for ASD and ADHD (OR=1.42, 95% CI: 1.23-1.65, I-2=58%; OR=1.26, 95% CI: 1.07-1.49, I-2=48%, respectively). Similar findings were obtained in women who were exposed to SSRIs/SNRIs before pregnancy, representing statistically significant association with ASD (OR=1.39, 95% CI: 1.24-1.56, I-2=33%) and ADHD (OR=1.63, 95% CI: 1.50-1.78, I-2=0%) in the Offspring, although they were not exposed to those medications in utero. Conclusions: Although we found an association between exposure to SSRIs/SNRIs during pregnancy and the risk for ASD and ADHD, an association with those disorders was also present for exposure pre-pregnancy, suggesting that the association might be due to unmeasured confounding. We are aiming to further assess the role of potential unmeasured confounding in the estimation of the association and perform a network meta-analysis.
引用
收藏
页码:896 / 906
页数:11
相关论文
共 50 条
  • [31] Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    Zhou, C.
    Fang, L.
    Chen, Y.
    Zhong, J.
    Wang, H.
    Xie, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (06) : 1243 - 1251
  • [32] Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    C. Zhou
    L. Fang
    Y. Chen
    J. Zhong
    H. Wang
    P. Xie
    Osteoporosis International, 2018, 29 : 1243 - 1251
  • [33] Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder
    Varigonda, Anjali L.
    Jakubovski, Ewgeni
    Taylor, Matthew J.
    Freemantle, Nick
    Coughlin, Catherine
    Bloch, Michael H.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (07): : 557 - 564
  • [34] Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder
    Jakubovski, Ewgeni
    Varigonda, Anjali L.
    Freemantle, Nicholas
    Taylor, Matthew J.
    Bloch, Michael H.
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (02): : 174 - 183
  • [35] Selective serotonin reuptake inhibitors in the treatment of major depressive disorder after brain trauma: Systematic review and meta-analysis
    Gao, Ren-Xian
    Zhang, Xiao-Na
    Zhu, Peng
    WORLD JOURNAL OF PSYCHIATRY, 2025, 15 (03):
  • [36] Selective Serotonin Reuptake Inhibitors and Dental Implant failure: A Systematic Review and Meta-Analysis
    Shariff, Jaffer Ahmed
    Abud, Daniela Gurpegui
    Bhave, Manasi B.
    Tarnow, Dennis P.
    JOURNAL OF ORAL IMPLANTOLOGY, 2023, 49 (04) : 436 - 443
  • [37] Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain
    Atluri, D. K.
    Chandar, A. K.
    Fass, R.
    Falck-Ytter, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 167 - 176
  • [38] Neurodevelopmental outcome of children exposed to Selective Serotonin Reuptake inhibitors (SSRI's) or Attention Deficit Hyperactivity Disorder (ADHD) stimulant medications during pregnancy: A prospective cohort study
    Berlin, Maya
    Belikov, Vika
    Beckenstein, Maayan
    TolChinsky, Irina
    Baran, Tomer Ziv
    Cohen, Rana
    Koren, Gideon
    Stepensky, David
    Matok, Ilan
    Berkovitch, Mati
    NEUROTOXICOLOGY AND TERATOLOGY, 2022, 92
  • [39] Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis
    Ramin Abdi Dezfouli
    Ali Hosseinpour
    Shera Ketabforoush
    Elnaz Daneshzad
    Middle East Current Psychiatry, 31
  • [40] Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis
    Dezfouli, Ramin Abdi
    Hosseinpour, Ali
    Ketabforoush, Shera
    Daneshzad, Elnaz
    MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2024, 31 (01):